Status:
UNKNOWN
Fibromyalgia Different Approaches: Acupuncture vs Migratens
Lead Sponsor:
Vittorio Schweiger
Conditions:
Fibromyalgia, Primary
Fibromyalgic Sindrome
Eligibility:
FEMALE
30-65 years
Brief Summary
Fibromyalgia or Fibromyalgic Sindrome (FMS) is a chronic debilitating pain syndrome, characterized by widespread chronic musculoskeletal pain and generalized painful hypersensitivity, which may be ass...
Detailed Description
Fibromyalgia or Fibromyalgic Sindrome (FMS) is a chronic debilitating pain syndrome, affecting about 2-4% of the general population, with an average peak between 30 and 50 years, but with a significan...
Eligibility Criteria
Inclusion
- patients not under pharmacological treatment for at least six months,
- patients with a new diagnosis of fibromyalgia (FM)
- hypovitaminosis D (vitamin D \<30 mg / ml) or patients already in oral supplementation with 1,000 IU / day. People with hypovitaminosis are treated with Vitamin D supplementation
- 30 - 65 years old
- female sex
- signature of informed consent
Exclusion
- patients treated with active drugs on the neuroendocrine system
- intake of drugs that can influence skeletal metabolism
- addition of other fibromyalgia medicines other than those included in the study, during the observational period
- allergies to components of the food supplement used
- use of oral hypoglycemic agents
- participation in other studies
- recent acupuncture treatments elsewhere
- severe psychiatric or neurological disorders
Key Trial Info
Start Date :
January 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 30 2020
Estimated Enrollment :
61 Patients enrolled
Trial Details
Trial ID
NCT04098757
Start Date
January 1 2019
End Date
December 30 2020
Last Update
September 23 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nrc
Verona, Italia, Italy, 37134